Nordic Bioscience is participating in ESC Congress 2022
"The four-day programme will be rich and stimulating, with important content for clinical practice and research.
The spotlight in 2022 is 'Cardiac imaging', with its profound implications for prevention, diagnosis, clinical decision-making, guiding of interventions and follow-up of therapeutic procedures.
Importantly, the most innovative scientific updates from late-breaking clinical trials and ground-breaking studies will be featured in our Hot Line Sessions and throughout the programme. A further highlight is the release of four new ESC Clinical Practice Guidelines, accompanied by state-of-the-art summaries to inform and improve clinical practice and implementation." (ESC 2022)
Nordic Bioscience will take part and discuss how our cardiac biomarkers, including the PRO-C6 (endotrophin) assay can be utilized in clinical research.
